Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers and high-dose statin use during pharmacological cardioversion for paroxysmal atrial fibrillation
2012-001260-29Phase 4Active
- Sponsor
- Fondazione Giglio
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin in Atrial fibrillation (AFib) (2 arms), sponsored by Fondazione Giglio. Primary endpoints: Successful pharmacological cardioversion rate and Time to recovery of sinus rhythm during pharmacological cardioversion. Started Mar 2012; status: active.
02
Drugs
atorvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2012-001260-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001260-29.